1 – 10 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
- The therapeutic potential of artesunate in hepatocellular carcinoma
- Inhibition of VEGFR2 attenuates steatosis and inflammation in a diet-induced mouse model for non-alcoholic steatohepatitis
- 2012
- A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
- Mitochondrial cardiotoxicity of a prototype HCV NS3-protease inhibitor is characterized by a specific electrocardiographic signature in mice
- Expansion of memory type CD8+t-cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high doses atg induction and rapamycin
- HNF1B deficiency causes ciliary defects in human cholangiocytes
- 2011
- Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
- HAb18G/CD147 Promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells
- Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease